El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) Selling, General, & Admin. Expense: E£21 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:NIPH El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
28 GF Score
Price E£372.30
! 4 Warning Signs
View Full Analysis

What is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Selling, General, & Admin. Expense?

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH +2.00% 28 Selling, General, & Admin. Expense is E£21 Mil as of Mar. 2026. GuruFocus rates CAI:NIPH with a GF Score™ of 28/100. The stock has 4 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's selling, general, & admin. expense for the three months ended in Mar. 2026 was E£0 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2026 was E£21 Mil.


El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile  (CAI:NIPH) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Selling, General, & Admin. Expense Related Terms


El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Selling, General, & Admin. Expense Chart

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Annual Data
Trend Jun24 Jun25
Selling, General, & Admin. Expense
62.58 68.32

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Selling, General, & Admin. Expense Get a 7-Day Free Trial 0.00 0.00 30.09 -9.29 0.00

CAI:NIPH vs ZTS, UTHR, VTRS: Selling, General, & Admin. Expense Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Selling, General, & Admin. Expense vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense falls into.


CAI:NIPH
28GF Score
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of E£21 Mil mean?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a Selling, General, & Admin. Expense of E£21 Mil as of Mar. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense too high?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Selling, General, & Admin. Expense is E£21 Mil. Overall, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense compare to ZTS and UTHR?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Selling, General, & Admin. Expense of E£21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Drug Manufacturers company?
A good Selling, General, & Admin. Expense depends on the Drug Manufacturers industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Selling, General, & Admin. Expense is E£21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile stock overvalued right now?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a current Selling, General, & Admin. Expense of E£21 Mil. The current Selling, General, & Admin. Expense is E£21 Mil. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH), the current Selling, General, & Admin. Expense is E£21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Business Description

Address Al-Sawah square, ElAmeria, Cairo, EGY
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
28GF Score

Get the complete analysis for CAI:NIPH

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£372.30
Price